(2S)-N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]-3,3-dimethyl-2-[[2-[(1-methyl-1-phenyl-ethyl)amino]acetyl]amino]butanamide

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (2S)-N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]-3,3-dimethyl-2-[[2-[(1-methyl-1-phenyl-ethyl)amino]acetyl]amino]butanamide
• 英文别名: (2S)-N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-3,3-dimethyl-2-[[2-(2-phenylpropan-2-ylamino)acetyl]amino]butanamide
• 化学式: C₃₇H₅₃N₅O₅S
• 分子量: 679.9
• InChiKey: WKKKHTHHBXDCCA-VOTWKOMSSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  48
• 可旋转键数：
  17
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  162
• 氢给体数：
  5
• 氢受体数：
  8

文献信息

• [EN] ALPHA, ALPHA-DISUBSTITUTED BENZYLGLYCINE DERIVATIVES AS HIV PROTEASE INHIBITORS<br/>[FR] DERIVES DE BENZYLGLYCINE ALPHA, ALPHA-DISUBSTITUES EN TANT QU'INHIBITEURS DE LA PROTEASE DU VIH
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2004043355A2

  公开（公告）日：2004-05-27

  This invention relates generally to alpha, alpha-disubstituted benzylglycine derivatives of the formula (I) or a stereoisomeric form, a mixture of stereoisomeric forms, or a pharmaceutically acceptable salt thereof, which are useful as HIV protease inhibitors, pharmaceutical compositions and diagnostic kits including the same, methods for using the same for treating viral infection or an assay standards or reagents, and intermediates and processes for making the same.